Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 454, Issue 2, Pages 653-659Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2013.05.027
Keywords
Paclitaxel; Poly(ethylene glycol); Prodrugs; Stability
Categories
Funding
- Progetti di Ricerca di Interesse Nazionale (PRIN, MIUR), Rome, Italy
Ask authors/readers for more resources
Paclitaxel has been found to be very effective against several human cancers; one of the major problems with its use is its poor solubility, which makes necessary its solubilization with excipients that can determine allergic reactions often severe. The aim of this study is to develop highly water-soluble prodrugs of paclitaxel. For this purpose we prepared a series of new paclitaxel-poly(ethylene glycol) (PEG) conjugates that were characterized and evaluated for their in vitro stability and cytotoxicity. In particular, in order to modulate the release of paclitaxel from prodrugs, we prepared different compounds introducing PEG in the drug C2' and/or C7 positions via ester or carbamate linkage. The conjugates were obtained in high purity and good yield. The carbamate prodrugs were highly stable in different media, while the compounds obtained linking PEG at C2' position through an ester bond showed lower stability. Finally, the cytotoxic activity of the conjugates was evaluated on two cancer cell lines and the results showed that all the derivatives had a reduced cytotoxicity compared to that of paclitaxel. (C) 2013 Elsevier B. V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available